Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review.
Strzelak A, Ratajczak A, Adamiec A, Feleszko W. · 2018
Read Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review. by Strzelak A, Ratajczak A, Adamiec A, Feleszko W. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5982072.txt.
Introduction
Strzelak and co-authors review how tobacco smoke alters immune responses in the lung. Their mechanistic review appeared in the International Journal of Environmental Research and Public Health. Smoke skews immunity toward chronic lung disease. Environmental smoke has also been linked to asthma in children. The authors gather current knowledge on the molecular routes. An oxidant and antioxidant imbalance sits at the centre.
That imbalance drives oxidative stress and mucosal inflammation, they report. Cytokines such as IL-8, IL-6, and TNF alpha rise. Epithelial cells grow leakier and make excess mucus. Macrophages and neutrophils flood in, and lymphocyte balance shifts. The authors argue for strict limits on smoke exposure.
Catalog record
| CREATOR | Strzelak A, Ratajczak A, Adamiec A, Feleszko W. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 148 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review By Agnieszka Strzelak, Aleksandra Ratajczak, Aleksander Adamiec, Wojciech Feleszko Published in: International Journal of Environmental Research and Public Health DOI: 10.3390/ijerph15051033 ABSTRACT Abstract Many studies have been undertaken to reveal how tobacco smoke skews immune responses contributing to the development of chronic obstructive pulmonary disease (COPD) and other lung diseases. Recently, environmental tobacco smoke (ETS) has been linked with asthma and allergic diseases in children. This review presents the most actual knowledge on exact molecular mechanisms responsible for the skewed inflammatory profile that aggravates inflammation, promotes infections, induces tissue damage, and may promote the development of allergy in individuals exposed to ETS. We demonstrate how the imbalance between oxidants and antioxidants resulting from exposure to tobacco smoke leads to oxidative stress, increased mucosal inflammation, and increased expression of inflammatory cytokines (such as interleukin (IL)-8, IL-6 and tumor necrosis factor α ([TNF]-α). Direct cellular effects of ETS on epithelial cells results in increased permeability, mucus overproduction, impaired mucociliary clearance, increased release of proinflammatory cytokines and chemokines, enhanced recruitment of macrophages and neutrophils and disturbed lymphocyte balance towards Th2. The plethora of presented phenomena fully justifies a restrictive policy aiming at limiting the domestic and public exposure to ETS. Keywords: tobacco, cigarette, smoke, lung, airway, immunity, asthma, atopy, allergy, children 1. INTRODUCTION Despite many efforts to reduce its prevalence, approximately six million people worldwide die due to tobacco use each year [1]. About 600,000 of them die from the effects of second-hand smoke. Apart from contributing to the pathogenesis of chronic obstructive pulmonary disease (COPD), hypertension, cardiovascular disease and cancer, cigarette smoking is a recognized risk factor for many chronic systemic diseases with inflammatory components such as atherosclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, Graves’ ophthalmopathy, and noninsulin-dependent diabetes mellitus [2,3]. Furthermore, smokers show increased susceptibility towards microbial infections (respiratory tract infections [RTI], bacterial meningitis and periodontitis) and poorer wound healing [2,3,4]. For these reasons, the capacity of cigarette smoke (CS) to distort immune homeostasis has gained much attention recently. In particular, great steps have been taken in the recent years to understand how cigarette smoke induces changes in the immune cell function in COPD patients. However, cigarette smoke induced alternations in immune responses in children, the most vulnerable population, remain an understudied area of focus. Current estimates are that 40–50% of all children across the world are exposed to second-hand smoke [5,6]. While cigarette smoke exposure (CSE) has been linked with an increased prevalence of childhood allergic diseases, the exact molecular mechanisms behind a skewed inflammatory profile that promote the development of allergy in smoke-exposed children are not completely understood. This review will focus on the effects of cigarette smoke on innate and adaptive immunity that can contribute to the development and exacerbation of allergic diseases in children. Due to the relative paucity of research in this area, the majority of reviewed mechanisms are based on the results of smoker and/or COPD patient studies and experimental models. 2. EXPOSURE TO CIGARETTE SMOKE AND ALLERGY Several separate lines of evidence suggest a positive association between cigarette smoke exposure and the development of allergy (Figure 1). In particular, exposure to parental smoking, both pre- and post-natally, can contribute to allergic disorders later in life. Second-hand smoke (SHS) is a well-known contributor to respiratory tract infections, otitis media, sudden infant death syndrome, as well as behavioral and cognitive problems in children [7,8]. SHS exposure is associated with increased incidence and severity of respiratory tract infections, such as respiratory syncytial virus (RSV) infection in neonates or pneumonia in younger children [9]. While early RSV infection is an important risk factor for recurrent wheezing or childhood asthma, SHS is estimated to contribute to 165,000 annual deaths from pneumonia in children under the age of 5 years [6,10]. [Figure: Cigarette smoke exposure-associated alternations in local and systemic immunity promoting inflammation and allergy development.] Mechanistically, it appears plausible that exposure to tobacco smoke can skew immune responses by impairing Th1-type and augmenting Th2-dependent responses, mainly by altering the immune functions of a variety of immune cells and aggravating the allergic inflammation and sensitization [3,11,12,13,14,15,16,17,18,19]. In line with this paradigm, Bozinovski et al. has recently demonstrated that cigarette smoke exposure promotes the release of interleukin (IL)-17A, a proinflammatory cytokine implicated in the pathogenesis of asthma, from nonconventional T-cell sources, such as natural killer (NK), natural killer T-cells (NKT) and γδ T-cells [20]. A vast body of evidence supports the linkage between parental smoking and markers of atopy in children, such as serum IgE level, eosinophilia, and positive skin-prick tests [21,22,23]. Of note, adult active smokers were also shown to display elevated serum IgE level [24]. Although systematic review from 1998 by Strachan and Cook on relationship between ETS exposure and allergic sensitization did not provide conclusive evidence, our more recent report demonstrated a positive correlation between exposure to cigarette smoke and increased levels of IgE concentrations and positive skin prick sensitization in children [25,26]. Recently, cigarette smoke exposure was significantly associated with IgE sensitization to cockroaches, grass pollen, and certain food allergens in children, and dose-dependent relationships were suggested [27]. Furthermore, children of smoking parents have been shown to have increased risk of wheeze, asthma, airways hyperresponsiveness, and allergic rhinitis [28,29,30,31,32]. In particular, epidemiological data link smoking with the development and the severity of asthma [33,34]. Active smoking worsens symptoms of asthma, precipitates decline in lung function and impairs therapeutic response to corticosteroids [33,35,36,37]. Of note, early changes in the airways were observed already in active smokers among adolescents with a short smoking history [38]. Concurrently, ETS exposure early in life is related to reduced lung function, asthma in childhood, and adult-onset asthma [39]. According to Burke et al., passive smoking increases the incidence of wheeze and asthma in children by at least 20% [40]. Further to this, exposure to tobacco smoke in early childhood impairs lung development, thus establishing an increased lifelong risk of poor lung health [41,42]. As in case of other smoke-induced diseases, however, an individual susceptibility to develop impaired lung function as a consequence of ETS exposure seems to have a non-negligible impact. Indeed, recently published results of the first genome-wide gene-by-ETS interaction study underlie three pathways through which exposure to cigarette smoke may potentially contribute to asthma development, namely the apoptosis, p38, mitogen-activated protein kinase (MAPK) and TNF pathways. All of them have been already implicated in impaired lung function in COPD [43]. Much ambiguity remains surrounding the association of cigarette smoke exposure and allergic rhinitis. While passive cigarette smoke exposure was associated with increased nasal congestion and current symptoms of rhinitis and rhinoconjunctivitis in children, other studies yielded counter results [44,45,46,47]. In adults, smoking worsens the symptoms of allergic rhinitis and increases the incidence of nasal polyposis in patients with perennial allergic rhinitis [48]. Cigarette smoke exerts cytotoxic and both proinflammatory and anti-inflammatory effects on nasal epithelial cells leading to increased reactive oxygen species (ROS) production, Toll-like receptor (TLR) 4 expression, lipopolysaccharide (LPS) and IL-17A synthesis [49,50,51]. Subsequent changes in sinonasal composition of immune cells include increased counts of neutrophils and monocyte-derived dendritic cells (DCs) demonstrated in nasal epithelium exposed to CS as